Several regulators (mammalian target of rapamycin, serum response factor, atrogin-1, myostatin, etc.)seem to modulate protein synthesis and degradation or transcription of muscle-specific genes during both sarcopenia and muscular dystrophy. Here, FBXO32 is linked to muscular dystrophy.